Rx only · Solution/ Drops · Ophthalmic
Cyclopentolate Hydrochloride
Brands: Cyclogyl · Cyclopentolate Hydrochloride
2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
2 active makers
2 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$3.180
Latest avg · Jul 22, 2026
-51%
Since Mar 19, 2025
2
Active US suppliers
100%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
2.2K
Rx · 2026 Q1
11K
Units dispensed
-24%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alcon Laboratories, Inc. | unknown | 6 | SUPPLYING |
| Bausch & Lomb Incorporated | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jan 18, 2016RECALLRecall (Class III): Cyclopentolate Hydrochloride Ophthalmic Solution USP, 1%, Packaged in a) 2 mL Bottles (NDC: 24208-735-01) and b) 15 mL …
Labeling: Incorrect or Missing Package Insert: Package insert is missing updates compared with reference drug insert. — Recalling firm: Bausch & Lomb, Inc. — U.S. Nationwide including Puerto Rico.
Pill